Skip to main content

Whispering Gallery Modes (WGM) for label free bioanalytics

Project description

Psst...use this combination if you want to make it through clinical trials to market

Effective action of drugs at their targets and reliably correct diagnoses of diseases and conditions have one very important thing in common, the correct selection of and interaction with the biomarkers used for targeting the drug or 'tagging' the disease from the start. Most failures of drugs in the clinical stage are related to the initial failure to correctly identify these interactions. To address this time-consuming and costly problem, the German SME Surflay Nanotec has developed WhisperSense, the first commercial label-free bioanalysis platform exploiting individual microparticles as label-free biosensors. The tiny spherical microparticles can be functionalised to recognise specific biological entities. The highly sensitive and specific platform also supports high-throughput screening. EU funding of the WhisperSense project helped the team improve technical performance, evaluate feasibility and develop a credible business plan.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

Surflay Nanotec GmbH
Net EU contribution
€ 50 000,00
Address
Max Planck Strasse 3
12489 Berlin
Germany

See on map

Region
Berlin Berlin Berlin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 21 429,00